Innovation Medical Management Co .,Ltd.
- Country
- ๐จ๐ณChina
- Ownership
- -
- Established
- 2003-09-30
- Employees
- 36
- Market Cap
- -
- Website
- http://www.chxyl.com
- Introduction
The company was founded in April 1997, completed its initial public offering of shares and listed on September 25, 2007. As the reform of the medical service industry continues to deepen, excellent private hospitals will achieve rapid development, and the profitability of target hospitals will continue to increase steadily in subsequent years. After the tran...
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
- Conditions
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00377546
- Locations
- ๐บ๐ธ
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
- First Posted Date
- 2006-07-07
- Last Posted Date
- 2007-06-01
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00349583
- Locations
- ๐บ๐ธ
Ophthalmic Consultants of Long Island, Rockville Centre, New York, United States
Efficacy of Cyclosporine for the Prevention and Treatment of Dry Eye Symptoms Following LASIK or Photorefractive Keratectomy
- First Posted Date
- 2006-07-07
- Last Posted Date
- 2008-09-26
- Lead Sponsor
- Innovative Medical
- Target Recruit Count
- 93
- Registration Number
- NCT00349440
- Locations
- ๐บ๐ธ
Southeastern Laser and Refractive Surgery, Greensboro, North Carolina, United States
Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2007-06-25
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00348582
- Locations
- ๐บ๐ธ
Dr. Francis, Pittsburgh, Pennsylvania, United States
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2007-06-01
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00348062
- Locations
- ๐บ๐ธ
Dr. Noecker, Pittsburgh, Pennsylvania, United States
Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2007-06-01
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00347802
- Locations
- ๐บ๐ธ
Dr. Noecker, Pittsburgh, Pennsylvania, United States
Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2007-06-01
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00347841
- Locations
- ๐บ๐ธ
Dr. Noecker, Pittsburgh, Pennsylvania, United States
Brimonidine Purite 0.15% Versus Dorzolamide 2% Used as Adjunctive Therapy to Latanoprost
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2007-06-01
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00348400
- Locations
- ๐บ๐ธ
Dr. Noecker, Pittsburgh, Pennsylvania, United States
Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2007-02-09
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00348023
- Locations
- ๐บ๐ธ
Dr. Noecker, Pittsburgh, Pennsylvania, United States
Ketorolac vs. Steroid in the Prevention of CME
- Conditions
- First Posted Date
- 2006-07-04
- Last Posted Date
- 2007-01-17
- Lead Sponsor
- Innovative Medical
- Registration Number
- NCT00348244
- Locations
- ๐บ๐ธ
Dr. Wittpenn, Stony Brook, New York, United States